Suppr超能文献

SARS-CoV-2 变体、RBD 突变、结合亲和力和抗体逃逸。

SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape.

机构信息

National Key Laboratory of Science and Technology on Advanced Composites in Special Environments, Center for Composite Materials and Structures, Harbin Institute of Technology, Harbin 150080, China.

School of Aerospace, Mechanical and Mechatronic Engineering, The University of Sydney, Sydney, NSW 2006, Australia.

出版信息

Int J Mol Sci. 2021 Nov 9;22(22):12114. doi: 10.3390/ijms222212114.

Abstract

Since 2020, the receptor-binding domain (RBD) of the spike protein of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been constantly mutating, producing most of the notable missense mutations in the context of "variants of concern", probably in response to the vaccine-driven alteration of immune profiles of the human population. The Delta variant, in particular, has become the most prevalent variant of the epidemic, and it is spreading in countries with the highest vaccination rates, causing the world to face the risk of a new wave of the contagion. Understanding the physical mechanism responsible for the mutation-induced changes in the RBD's binding affinity, its transmissibility, and its capacity to escape vaccine-induced immunity is the "urgent challenge" in the development of preventive measures, vaccines, and therapeutic antibodies against the coronavirus disease 2019 (COVID-19) pandemic. In this study, entropy-enthalpy compensation and the Gibbs free energy change were used to analyze the impact of the RBD mutations on the binding affinity of SARS-CoV-2 variants with the receptor angiotensin converting enzyme 2 (ACE2) and existing antibodies. Through the analysis, we found that the existing mutations have already covered almost all possible detrimental mutations that could result in an increase of transmissibility, and that a possible mutation in amino-acid position 498 of the RBD can potentially enhance its binding affinity. A new calculation method for the binding energies of protein-protein complexes is proposed based on the entropy-enthalpy compensation rule. All known structures of RBD-antibody complexes and the RBD-ACE2 complex comply with the entropy-enthalpy compensation rule in providing the driving force behind the spontaneous protein-protein docking. The variant-induced risk of breakthrough infections in vaccinated people is attributed to the L452R mutation's reduction of the binding affinity of many antibodies. Mutations reversing the hydrophobic or hydrophilic performance of residues in the spike RBD potentially cause breakthrough infections of coronaviruses due to the changes in geometric complementarity in the entropy-enthalpy compensations between antibodies and the virus at the binding sites.

摘要

自 2020 年以来,新型严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的刺突蛋白的受体结合域(RBD)一直在不断突变,在“关注变体”的背景下产生了大多数显著的错义突变,可能是为了应对人类人群免疫特征的疫苗驱动变化。特别是德尔塔变体已成为该流行的最主要变体,并在疫苗接种率最高的国家传播,使世界面临新一波传染病的风险。了解导致 RBD 结合亲和力、传染性和逃避疫苗诱导免疫能力变化的突变的物理机制,是开发针对 2019 年冠状病毒病(COVID-19)大流行的预防措施、疫苗和治疗性抗体的“当务之急”。在这项研究中,使用熵-焓补偿和吉布斯自由能变化来分析 RBD 突变对 SARS-CoV-2 变体与受体血管紧张素转换酶 2(ACE2)和现有抗体结合亲和力的影响。通过分析,我们发现现有突变已经涵盖了几乎所有可能导致传染性增加的有害突变,并且 RBD 中氨基酸位置 498 的可能突变可能增强其结合亲和力。基于熵-焓补偿规则,提出了一种新的蛋白质-蛋白质复合物结合能计算方法。所有已知的 RBD-抗体复合物和 RBD-ACE2 复合物的结构都符合熵-焓补偿规则,为自发的蛋白质-蛋白质对接提供了驱动力。接种疫苗的人突破性感染的风险归因于 L452R 突变降低了许多抗体的结合亲和力。在刺突 RBD 中残基的疏水性或亲水性性能发生反转的突变,由于在结合部位抗体和病毒之间的熵-焓补偿中几何互补性的变化,可能导致冠状病毒的突破性感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bae/8619214/b16cd5204712/ijms-22-12114-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验